Aadi Bioscience Analysis

Aadi Stock Analysis Notes

About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aadi Bioscience recorded a loss per share of 2.28. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people. For more info on Aadi Bioscience please contact David Lennon at 424 744 8055 or go to https://aadibio.com.

Aadi Bioscience Investment Alerts

Aadi Bioscience Upcoming and Recent Events

Aadi Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 97.21 M.

Aadi Profitablity

The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.49.

Technical Drivers

As of the 23rd of March, Aadi Bioscience shows the mean deviation of 4.08, and Risk Adjusted Performance of 0.0099. Aadi Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aadi Bioscience Price Movement Analysis

Aadi Bioscience Insider Trading Activities

Aadi Bioscience Outstanding Bonds

Aadi Bioscience Predictive Daily Indicators

Aadi Bioscience Forecast Models

Aadi Bioscience's time-series forecasting models are one of many Aadi Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aadi Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aadi Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aadi shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Aadi Bioscience. By using and applying Aadi Stock analysis, traders can create a robust methodology for identifying Aadi entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.